Skip to main content
. Author manuscript; available in PMC: 2014 Mar 1.
Published in final edited form as: Contemp Clin Trials. 2013 Jan 6;34(2):326–335. doi: 10.1016/j.cct.2012.12.009

Table 6.

Power Analysis for EPA/DHA Treatment

Outcome Standardized effect size (change/standard deviation) Estimated Power1
ACQ 0.5/0.45 = 1.1 98
ASUI 0.1/0.1 = 1.0 98
8-isoprostane 1.0/0.7 = 1.43 99
FEV1/FVC 0.05/0.07 = 0.71 83
FEV1 0.07/0.11 = 0.64 75
1

Based on 90 completing intervention, 67 treated, 23 controls;

ACQ – asthma control questionnaire; ASUI – asthma symptom utility index, FEV – forced expiratory volume, FVC – forced vital capacity